Skip to main content

Kyle

Analyst

Stifel

Equibles does not estimate personal net worth.

About Kyle

Kyle is recorded as Analyst at Stifel. Kyle has spoken on 1 earnings call across 1 company, most recently for Altimmune, Inc. on November 12, 2026. The companies whose calls Kyle spoke on are classified in the Healthcare sector.

Kyle on recent calls

“On the AUD primary, you guys selected who RDO and then the COHDD secondary. Just curious why you chose one over the other, and then how receptive that is from FDA.”
Analyst — Stifel, Q3 FY2026 Earnings conference call (announced in 8-K) ·

Affiliation history

  • Stifel

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity